Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: Are the metabolic syndrome and an increase in cardiovascular risk unavoidable

. (2018). Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: Are the metabolic syndrome and an increase in cardiovascular risk unavoidable. Vessel Plus, 2(-), 0-0. SID. https://sid.ir/paper/785717/en

. Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: Are the metabolic syndrome and an increase in cardiovascular risk unavoidable. Vessel Plus[Internet]. 2018;2(-):0-0. Available from: https://sid.ir/paper/785717/en

, “Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: Are the metabolic syndrome and an increase in cardiovascular risk unavoidable,” Vessel Plus, vol. 2, no. -, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/785717/en